InstalabLoading...
InstalabLoading...
If a doctor prescribes you doxycycline for an infection or as ongoing prophylaxis, the drug only works if the bacteria it targets cannot defend themselves against it. Tetracycline resistance is the property that determines whether those bacteria win or lose that fight.
This test looks for tetracycline resistance genes carried by the bacteria living in your gut. The result reflects how much of the tetracycline-class antibiotic family (doxycycline, minocycline, tetracycline, and the newer tigecycline and omadacycline) those bacteria are equipped to resist, both for current treatment decisions and for future ones.
Tetracycline resistance is not a human hormone or metabolite. It is a set of bacterial genes and proteins that allow microbes in your stool to survive exposure to tetracycline-class drugs. The genes (called tet genes) are typically grouped by the strategy they encode: efflux pumps that push the drug out of the bacterial cell, ribosomal protection proteins that shield the bacterial machinery the drug normally jams, and enzymes that chemically inactivate the drug itself.
These genes are most often carried on small pieces of mobile DNA (plasmids and transposons) that bacteria can hand off to one another, even across species. That is why a resistance gene that started in a foodborne bug can end up in a harmless gut bacterium, and from there potentially in a future pathogen.
Your gut is one of the largest reservoirs of antibiotic resistance genes in the body. A metagenomic study of 246 healthy individuals found that tetracycline resistance genes were the most abundant antibiotic resistance genes in human gut microbiota and that they accumulated and became more complex with age.
The genes carried by your gut bacteria today shape what happens when you next take a tetracycline. They also influence what happens to people around you, since these genes can spread through close contact and shared environments.
Tetracycline resistance is widespread enough across common pathogens that it routinely changes which drugs actually work. The numbers vary a lot depending on what the bacteria are and where they live.
| Where Resistance Was Measured | What Was Found | Source |
|---|---|---|
| Group B Streptococcus in pregnant women | About 94% of isolates were resistant to tetracycline; most carried tet(M) and/or tet(O) | Zakerifar et al., 2023 |
| Clinical Enterococcus faecalis (global) | About 67% of isolates were resistant to tetracycline, among the highest of all drugs tested | Guan et al., 2024 |
| Salmonella from poultry and pork | About 71% of isolates were resistant, dominated by tet(A) and tet(B) on plasmids | Pavelquesi et al., 2021 |
What this means for you: tetracycline-class drugs are still go-to options for acne, certain respiratory infections, tick-borne illnesses, sexually transmitted infections, and as part of doxy-PEP (post-exposure prophylaxis). When resistance is high in the bacteria most likely to cause your infection, the antibiotic may simply not work, and a backup option will be needed.
Third-generation tetracyclines (tigecycline, eravacycline, and omadacycline) were specifically designed to bypass the older resistance tricks like efflux pumps and ribosomal protection. They are often used as last-line drugs for serious multidrug-resistant infections.
But resistance is already catching up. The Tet(X) family of enzymes can chemically inactivate even these newer drugs, and overactive multidrug efflux pumps and mutations in bacterial ribosomes are also eroding their effectiveness. Tracking what your gut harbors gives a window into how prepared your microbiome is to defeat both old and new tetracyclines.
The most direct way to push tetracycline resistance up is to take a tetracycline. In a randomized trial of 220 men who have sex with men and transgender women using doxycycline 200 mg after condomless sex (a regimen called doxy-PEP), the share of the gut resistome made up of tetracycline resistance genes rose from 46% to 51% over six months, and actively expressed tetracycline resistance genes climbed from 4% to 15% over the same period.
A separate systematic review of randomized trials found that 2 to 18 weeks of oral tetracyclines (doxycycline, tetracycline, oxytetracycline, or minocycline) increased tetracycline-resistant bacteria in subgingival, gastrointestinal, and upper respiratory tract flora. The effect on resistance to other antibiotic classes was generally small or transient. The change is real, not a measurement artifact, and can persist for weeks after the drug is stopped.
Doxy-PEP is being used to prevent bacterial sexually transmitted infections, and it works partly because doxycycline can clear susceptible bugs before they cause an infection. The catch is that it only works for bacteria that are still susceptible. A systematic review found median tetracycline resistance of about 54% in Neisseria gonorrhoeae globally, with rates exceeding 80% in some regions and rising over time.
In a substudy of the ANRS 174 DOXYVAC randomized trial of 545 men, doxy-PEP use was linked to higher rates of high-level tetracycline resistance and reduced susceptibility to cefixime in gonorrhea isolates. If you use doxy-PEP, knowing your gut resistome gives you and your clinician a way to track whether the strategy is selecting for harder-to-treat bacteria over time.
This is a Tier 3 research-grade marker. There are no standardized clinical cutpoints that say a given level of tetracycline resistance genes is normal or abnormal in a healthy person. The thresholds that exist in microbiology apply to bacterial isolates grown in the lab, not to the mixed gene pool found in your gut.
For context, the standard microbiology cutpoints used to classify a bacterial strain as resistant come from EUCAST and CLSI guidelines and US national surveillance. They look like this:
| Setting | Resistance Definition | Source |
|---|---|---|
| Neisseria gonorrhoeae (global, EUCAST and CLSI) | Minimum inhibitory concentration above 1 milligram per liter | Do et al., 2025 |
| Neisseria gonorrhoeae (US national surveillance) | Resistant at 2 micrograms per milliliter or higher; high-level resistant at 16 or higher | Wondmeneh et al., 2025 |
| Tetracycline-class drugs (research models) | To suppress new resistance from emerging, drug exposure should keep AUC/MIC at 50 or higher | Sumi et al., 2019 |
These ranges classify single bacterial isolates and do not translate into a personal target for your gut resistome. Cutpoints do not vary by age, sex, or ethnicity. Your own result is most useful when compared to your previous results from the same lab using the same method, since assays for resistance gene detection are not yet standardized across providers.
The gut resistome is a moving target. It shifts when you take antibiotics, change your diet, get an infection, or simply age. A single snapshot tells you what is happening today, but the more useful information is the direction of travel.
Get a baseline now. If you start a course of doxycycline, doxy-PEP, or any other tetracycline, retest at 3 to 6 months to see whether your resistance gene load is climbing. If you make a deliberate change like a diet shift, a microbiome restoration program, or a course of probiotics, retest at 3 to 6 months to see whether the change moved the needle. After that, annual monitoring is reasonable for anyone using tetracyclines repeatedly or working actively to reduce their resistome.
A high tetracycline resistance signal is not a diagnosis. It is a flag that the bacteria in your gut are well-equipped to defeat this antibiotic class, which matters most when you actually need one. The right next steps depend on context.
A single result can be distorted by recent events. Consider these factors before drawing conclusions:
None of these factors mean the test is wrong, only that a single reading taken at a noisy moment may not represent your usual state. The trend across multiple readings is more informative than any one number.
Evidence-backed interventions that affect your Tetracycline Resistance level
Tetracycline Resistance is best interpreted alongside these tests.